Efficacy and Safety Data for Rituximab (Anti-CD20) in the Treatment of Pemphigus Vulgaris: A Retrospective, Single-Center Study

The real-life efficacy and safety of secukinumab therapy (150 and 300 mg) in patients with moderate-to-severe plaque psoriasis: A twelve week, single center, retrospective

Blood pressure control rates in baseline systolic blood pressure (SBP) subgroups, patients with isolated sys- tolic hypertension (ISH) and diabetes mellitus.. Response rates

In this study, demographic data were collected for each participant, including the Fitzpatrick skin type, the duration and severity of acne, the most recently prescribed treat-

We used rituximab and IVIG which are combined last step treatment regimens for our case and achieved to treat her.. We think that our case report will contribute to literature

Autoimmune Connective Tissue Diseases ISuccessful results with rituximab have been reported in cutaneous lupus erythematosus, especially in subacute cutaneous lupus, in

It included details like age, gender, weight, duration of acne, method of calculation of severity of acne, history of depression and the scoring system used to assess it,

In dermatology, rituximab has gained popularity for the treatment of refractory pemphigus vulgaris.. However, there are only a few case reports regarding the treatment of

compared of efficacy of topical clindamycin and niaci- namide combination with plain clindamycin for the treatment of acne vulgaris and acne resistant to topical antibiotics..